Related Experiment Video
Updated: Mar 19, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Propofol Use in Pediatric Patients With Food Allergy and Eosinophilic Esophagitis
Pooja Mehta1, Shikha S Sundaram, Glenn T Furuta
1*Digestive Health Institute †Gastrointestinal Eosinophilic Diseases Program, Digestive Health Institute ‡Department of Biostatistics §Gastrointestinal Eosinophilic Diseases Program, Section of Allergy and Immunology ¶Department of Anesthesiology, Children's Hospital Colorado, University of Colorado, School of Medicine, Aurora, CO.
Insights
Propofol is safe for children with eosinophilic esophagitis (EoE) and food allergies, despite contraindications. This study found no increased complications when propofol was used in these pediatric patients.
Area of Science:
- Anesthesiology
- Pediatric Gastroenterology
- Allergy and Immunology
Background:
- Propofol, a common anesthetic, carries a contraindication for patients with egg or soy allergies.
- Rising rates of food allergies and eosinophilic esophagitis (EoE) present challenges to this contraindication.
- Clinical practice regarding propofol use in pediatric patients with these allergies requires investigation.
Purpose of the Study:
- To examine the utilization of propofol for esophagogastroduodenoscopies in children with EoE and food allergies.
- To assess the safety and complication rates associated with propofol use in this specific pediatric population.
Main Methods:
- Retrospective observational study of 1365 esophagogastroduodenoscopies.
- Data collected from January 2013 to June 2014.
- Statistical analysis included Student t tests, chi-square tests, Fisher exact tests, and multivariable logistic regression.
Main Results:
- Propofol was administered less frequently to patients with egg or soy allergy and those with EoE.
- This reduced usage persisted even after accounting for the presence of food allergies.
- No significant difference in complication rates was observed between patients who received propofol and those who did not.
Conclusions:
- Propofol can be safely administered to pediatric patients with EoE and food allergies.
- The study suggests that the contraindication may be overly cautious in this patient group.
- Further single-center review indicates propofol is a safe option for these children.
Abstract:
Propofol is a safe, well-tolerated anesthetic that is labeled as contraindicated in patients with egg or soy allergy. This contraindication has become increasingly problematic given the rising incidence of food allergy and eosinophilic esophagitis (EoE). To address this issue, we studied practice patterns of propofol use for esophagogastroduodenoscopies in children with EoE and food allergies at our institution. A retrospective observational study of 1365 esophagogastroduodenoscopies from January 2013 to June 2014 was performed. Data were analyzed using Student t tests, chi square tests, Fisher exact tests, and multivariable logistic regression. We found that propofol was used significantly less in patients with egg or soy allergy, and in patients with EoE, even after adjusting for the presence of food allergy. There was no difference in complication rates relative to propofol use. Propofol was used safely in pediatric patients with EoE and food allergy in this limited single-center review.
Related Concept Videos
Parenteral Anesthetics: Overview
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Dosing: Infants and Children
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...

